May 24 (Reuters) - Britain's FTSE 100 .FTSE index is seen opening 14 points higher at 7,245

on Friday, according to financial bookmakers.

* GSK: British drugmaker GlaxoSmithKline GSK.L said on Thursday it will reintroduce incentive payments for sales representatives in some countries to retain talent after stopping them for years in the wake of scandals over illegal sales practices.

* GSK: GlaxoSmithKline Plc GSK.L said on Thursday its shingles vaccine had been approved for use in China in adults aged 50 and above.

* THOMAS COOK: Thomas Cook TCG.L has received a takeover approach for its Nordic operations from private equity group Triton, the tour operator said on Thursday, adding that it was considering the unsolicited offer but talks were at a preliminary stage.

* ICAG: British Airways will resume flights to Pakistan next week a decade after it suspended operations following a major hotel bombing, becoming the first Western airline to restart flights to the South Asian country.

* ITV: British broadcaster ITV ITV.L has signed a new four-year deal with the English Football Association (FA) that will make FA Cup matches entirely free-to-air to viewers from the 2021-22 season.

* The UK blue chip index lost 1.4% on Thursday as heightened concerns over the course of Brexit and mounting pressure on Prime Minister Theresa May to step down weighed heavily on Britain's mid-cap index and domestically-focused blue-chip stocks on Thursday.

* For more on the factors affecting European stocks, please click on: LIVE/

* UK CORPORATE DIARY:

Westminster Group PLC

WSG.L

Full Year 2018 Earnings

Urban Logistics Reit PLC

SHED.L

Full Year 2019 Earnings

Spectris PLC

SXS.L

Trading Statement

Mothercare Plc

MTC.L

Preliminary Results

TODAY'S UK PAPERS > Financial Times PRESS/FT > Other business headlines PRESS/GB

(Reporting by Tanishaa Nadkar in Bengaluru)

((tanishaa.nadkar@thomsonreuters.com; Within UK +44 20 7542 1810; Outside UK +91 80 6749 1691; Reuters Messaging: tanishaa.nadkar.thomsonreuters.com@reuters.net))

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.